Please login to the form below

Not currently logged in
Email:
Password:

Former Roche CEO and chairman joins Arix Bioscience

Dr Franz Humer becomes a senior independent director

Arix Bioscience Dr Franz HumerHealthcare and life science company Arix Bioscience has appointed Dr Franz Humer as a senior independent director.

Most recently, Dr Humer served as chairman and chief executive at Roche, having joined the company as head of pharmaceuticals in 1995 before becoming chief operating officer in 1996.

He is currently chairman of Diageo, a consumer goods company, and a non-executive director of Chugai Pharmaceuticals, Citigroup and Kite Pharma.

Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz's stature.

“His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.

“Franz further strengthens a very experience board of executive and non-executive directors.”

10th November 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....